The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses

BACKGROUND: MEDI8852 is a novel monoclonal antibody (mAb) that neutralizes both group I and group II influenza A viruses (IAVs) in vitro. We evaluated whether MEDI8852 was effective for prophylaxis and therapy against representative group I (H5N1) and group II (H7N9) pandemic IAVs in mice and ferret...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Infect Dis
Hoofdauteurs: Paules, Catharine I, Lakdawala, Seema, McAuliffe, Josephine M, Paskel, Myeisha, Vogel, Leatrice, Kallewaard, Nicole L, Zhu, Qing, Subbarao, Kanta
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2017
Onderwerpen:
Major Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853468/
https://ncbi.nlm.nih.gov/pubmed/28633457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix292
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items